IVF-ET in women with refractory polycystic ovarian disease

Jack Ashkenazi, Dov Feldberg, Dov Dicker, Arie Yeshaya, Daniel Ayalon, Jack A. Goldman*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Polycystic ovarian disease may be a cause of hormonal infertility. This condition is often refractory to therapy. Three groups of randomly chosen women with refractory polycystic ovarian disease (PCOD) were treated by induction of ovulation with pFSH/hCG, pFSH/hMG/hCG or after down-regulation of the ovaries with a GnRH analogue (Decapeptyl). Out of 18 patients six conceived in the first in vitro fertilization-embryo transfer (IVF-ET) cycle, and two further women conceived in a later cycle. It is suggested that patients with refractory PCOD should be referred for IVF-ET therapy, possibly after treatment with a GnRH analogue.

Original languageEnglish
Pages (from-to)157-161
Number of pages5
JournalEuropean Journal of Obstetrics, Gynecology and Reproductive Biology
Issue number2
StatePublished - Feb 1989


  • GnRH analogue
  • In vitro fertilization
  • Polycystic ovarian disease


Dive into the research topics of 'IVF-ET in women with refractory polycystic ovarian disease'. Together they form a unique fingerprint.

Cite this